ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AVDL Avadel Pharmaceuticals PLC

17.66
-0.43 (-2.38%)
Apr 24 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 444,065
Bid Price 17.36
Ask Price 18.74
News -
Day High 18.45

Low
9.50

52 Week Range

High
18.85

Day Low 17.52
Company Name Stock Ticker Symbol Market Type
Avadel Pharmaceuticals PLC AVDL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.43 -2.38% 17.66 20:00:00
Open Price Low Price High Price Close Price Prev Close
18.06 17.52 18.45 17.66 18.09
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
6,521 444,065 $ 17.88 $ 7,941,029 - 9.50 - 18.85
Last Trade Time Type Quantity Stock Price Currency
16:00:27 priorref 161 $ 17.66 USD

Avadel Pharmaceuticals (AVDL) Options Flow Summary

Overall Flow

Bullish

Net Premium

93k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

100.00%

Sweeps Ratio

0.00%

Avadel Pharmaceuticals PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 27.96M -160.28M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Avadel Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No AVDL Message Board. Create One! See More Posts on AVDL Message Board See More Message Board Posts

Historical AVDL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week18.0918.4716.7017.641,171,975-0.43-2.38%
1 Month16.4718.8515.2517.12946,4581.197.23%
3 Months14.5918.8511.8215.491,235,5833.0721.04%
6 Months10.5618.859.5014.541,044,4217.1067.23%
1 Year10.5018.859.5014.09909,3477.1668.19%
3 Years8.3018.851.057.97953,8559.36112.77%
5 Years1.1118.851.037.66810,79416.551,490.99%

Avadel Pharmaceuticals Description

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.

Your Recent History

Delayed Upgrade Clock